| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.00316.2007 |
| P698 | PubMed publication ID | 18024550 |
| P2093 | author name string | Wayne R Giles | |
| Jason H Haga | |||
| Colleen S Kondo | |||
| Betty S Hu | |||
| Lee K Landeen | |||
| Nakon Aroonsakool | |||
| Dorothy A Dederko | |||
| P2860 | cites work | Computer model of action potential of mouse ventricular myocytes. | Q47606383 |
| Mathematical model of an adult human atrial cell: the role of K+ currents in repolarization | Q48732077 | ||
| A novel high-affinity inhibitor for inward-rectifier K+ channels | Q48932137 | ||
| Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte | Q59192165 | ||
| Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 | Q24314828 | ||
| Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation | Q24629370 | ||
| The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocks | Q24674614 | ||
| Cell type-specific localization of human cardiac S1P receptors | Q28215436 | ||
| Cardiac excitation-contraction coupling | Q28216347 | ||
| The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins | Q28235712 | ||
| Sphingosine-1-phosphate signaling in the cardiovascular system | Q28286951 | ||
| Sphingosine 1-phosphate analogs as receptor antagonists | Q30435361 | ||
| Artifactual contractions triggered by field stimulation of cardiomyocytes | Q33210707 | ||
| Molecular elements of ion permeation and selectivity within calcium channels | Q33726313 | ||
| Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. | Q34101073 | ||
| The peptide components of bee venom | Q34165099 | ||
| Gbetagamma binding increases the open time of IKACh: kinetic evidence for multiple Gbetagamma binding sites | Q34179830 | ||
| Modulation of myocardial contractility by lysophosphatidic acid (LPA). | Q34182113 | ||
| Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy | Q34322524 | ||
| Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites | Q35048357 | ||
| Activation of the atrial KACh channel by the betagamma subunits of G proteins or intracellular Na+ ions depends on the presence of phosphatidylinositol phosphates | Q35806004 | ||
| Na(+)--Ca2+ exchange in the regulation of cardiac excitation-contraction coupling | Q36151260 | ||
| Calcium signaling in cardiac ventricular myocytes. | Q36225118 | ||
| Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology | Q36846525 | ||
| S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate | Q40405662 | ||
| Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. | Q40975598 | ||
| The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase | Q42496982 | ||
| Serum contains a potent factor that decreases beta-adrenergic receptor-stimulated L-type Ca2+ current in cardiac myocytes. | Q42508097 | ||
| A model of the L-type Ca2+ channel in rat ventricular myocytes: ion selectivity and inactivation mechanisms | Q42637569 | ||
| The role of muscarinic K(+) channels in the negative chronotropic effect of a muscarinic agonist | Q43863097 | ||
| Modeling beta-adrenergic control of cardiac myocyte contractility in silico | Q44583904 | ||
| Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate | Q44734550 | ||
| Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. | Q44745339 | ||
| Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. | Q44842087 | ||
| The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis | Q44892426 | ||
| Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents | Q46376442 | ||
| Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury | Q46503010 | ||
| Effects of L-type Ca2+ channel modulation on direct myocardial effects of diazepam and midazolam in adult rat ventricular myocytes | Q46900451 | ||
| P433 | issue | 2 | |
| P304 | page(s) | H736-49 | |
| P577 | publication date | 2007-11-16 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes. | |
| P478 | volume | 294 |
| Q30827729 | Ablation of Sphingosine 1-Phosphate Receptor Subtype 3 Impairs Hippocampal Neuron Excitability In vitro and Spatial Working Memory In vivo |
| Q33611979 | Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. |
| Q33593619 | Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects |
| Q30496446 | Disruption of protein kinase A localization using a trans-activator of transcription (TAT)-conjugated A-kinase-anchoring peptide reduces cardiac function |
| Q42712218 | Early Impairment of Transmural Principal Strains in the Left Ventricular Wall After Short-Term, High-Fat Feeding of Mice Predisposed to Cardiac Steatosis |
| Q42495601 | Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes. |
| Q46480858 | Fingolimod (Gilenya® ) in multiple sclerosis: bradycardia, atrioventricular blocks, and mild effect on the QTc interval. Something to do with the L-type calcium channel? |
| Q46079105 | Fingolimod confers neuroprotection through activation of Rac1 after experimental germinal matrix hemorrhage in rat pups |
| Q37898924 | G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function |
| Q28114943 | Identification of a Kir3.4 mutation in congenital long QT syndrome |
| Q36898368 | Implication of sphingosin-1-phosphate in cardiovascular regulation |
| Q38044174 | Lysophospholipid receptor activation of RhoA and lipid signaling pathways |
| Q87503251 | Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics |
| Q34113032 | Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion |
| Q38111276 | Regulation of ion channels by membrane lipids |
| Q57802697 | Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse |
| Q89335138 | Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers |
| Q46228881 | Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection |
| Q37162539 | Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction |
| Q41531207 | Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System |
| Q33715344 | Sphingosine kinase and sphingosine 1-phosphate in cardioprotection |
| Q27001065 | Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress |
| Q42746435 | Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning |
| Q28235893 | Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection |
| Q39687474 | Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. |
| Q37413862 | Sphingosine-1-phosphate receptor signalling in the heart |
| Q61450263 | The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis |
| Q33613072 | The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion |
| Q34097632 | Transmural heterogeneity of repolarization and Ca2+ handling in a model of mouse ventricular tissue |
Search more.